Sarcoglycan, gamma (35kDa Dystrophin-Associated Glycoprotein) (SGCG) Peptid
Kurzübersicht für Sarcoglycan, gamma (35kDa Dystrophin-Associated Glycoprotein) (SGCG) Peptid (ABIN938493)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- FTVDEKEVVV GTDKLRVTGP EGALFEHSVE TPLVRADPFQ DLRLESPTRS
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SGCG antibody,
Alternative Names: SGCG control peptide, SGCG antibody Blocking Peptide, Anti-SGCG Blocking Peptide, Sarcoglycan Gamma Blocking Peptide, 35Kda Dystrophin-Associated Glycoprotein Blocking Peptide, A4 Blocking Peptide, DAGA4 Blocking Peptide, DMDA Blocking Peptide, DMDA1 Blocking Peptide, LGMD2C Blocking Peptide, MAM Blocking Peptide, MGC130048 Blocking Peptide, SCARMD2 Blocking Peptide, SCG3 Blocking Peptide, TYPE Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- SGCG (Sarcoglycan, gamma (35kDa Dystrophin-Associated Glycoprotein) (SGCG))
-
Hintergrund
- Gamma-sarcoglycan is one of several sarcolemmal transmembrane glycoproteins that interact with dystrophin, probably to provide a link between the membrane associated cytoskeleton and the extracellular matrix. Defects in the protein can lead to early onset autosomal recessive muscular dystrophy, in particular limb-girdle muscular dystrophy, type 2C (LGMD2C).Gamma-sarcoglycan is one of several sarcolemmal transmembrane glycoproteins that interact with dystrophin, probably to provide a link between the membrane associated cytoskeleton and the extracellular matrix. Defects in the protein can lead to early onset autosomal recessive muscular dystrophy, in particular limb-girdle muscular dystrophy, type 2C (LGMD2C).
-
Molekulargewicht
- 32 kDa
Target
-